Akzo Nobel Appoints Senior Vice President Human Resources.Business Editors ARNHEM, the Netherlands--(BUSINESS WIRE)--Sept. 19, 2003 Akzo Nobel Akzo Nobel is a multinational company, active in the fields of healthcare products, coatings and chemicals. Headquartered in Amsterdam, the Netherlands, the company has activities in more than 80 countries, and employs approximately 62,000 people. has appointed Paul L. Matson (54) as Senior Vice President of Human Resources The fancy word for "people." The human resources department within an organization, years ago known as the "personnel department," manages the administrative aspects of the employees. to succeed Olle Werner who will retire this month. Mr. Matson will take up his new post on October 1, 2003, and will report to Hans Wijers Gerardus Johannes (Hans) Wijers (born November 11, 1951) is the current CEO of Akzo Nobel. From 1994 until 1998 he was a minister of Economic Affairs of the Netherlands. Wijers studied Economy at the Rijksuniversiteit Groningen, where he graduated in 1976. , Chairman of the Board of Management of Akzo Nobel. A U.S. citizen with extensive experience with operations in Europe and Asia, Mr. Matson has 30 years of business experience covering all aspects of the human resources field. He has worked in international companies in the chemical and pharmaceutical industries, such as Bayer, SmithKline Beckman, and most recently Pharmacia as Global Director of Human Resources. Note for the editor Akzo Nobel, based in the Netherlands, serves customers throughout the world with healthcare products, coatings and chemicals. Consolidated sales for 2002 totaled EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 14 billion. The Company currently employs approximately 66,000 people in more than 80 countries. Financial results for the third quarter will be published on October 17, 2003. Internet: www.akzonobel.com Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement(1) This press release may contain statements which address such key issues as Akzo Nobel's growth strategy, future financial results, market positions, product development, pharmaceutical products in the pipeline, and product approvals. Such statements should be carefully considered, and it should be understood that many factors could cause forecasted and actual results to differ from these statements. These factors include, but are not limited to, price fluctuations, currency fluctuations, developments in raw material and personnel costs, physical and environmental risks, legal issues, and legislative, fiscal, and other regulatory measures. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies. For a more complete discussion of the risk factors affecting our business please refer to our Annual Report on Form 20-F filed with the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. Securities and Exchange Commission. A copy of which can be found on the Company's website www.akzonobel.com. (1) Pursuant to the U.S. Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and 1995. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion